Literature DB >> 24169821

Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.

K Skhirtladze1, E M Base, A Lassnigg, A Kaider, S Linke, M Dworschak, M J Hiesmayr.   

Abstract

BACKGROUND: Infusion of 5% human albumin (HA) and 6% hydroxyethyl starch 130/0.4 (HES) during cardiac surgery expand circulating volume to a greater extent than crystalloids and would be suitable for a restrictive fluid therapy regimen. However, HA and HES may affect blood coagulation and could contribute to increased transfusion requirements.
METHODS: We randomly assigned 240 patients undergoing elective cardiac surgery to receive up to 50 ml kg(-1) day(-1) of either HA, HES, or Ringer's lactate (RL) as the main infusion fluid perioperatively. Study solutions were supplied in identical bottles dressed in opaque covers. The primary outcome was chest tube drainage over 24 h. Blood transfusions, thromboelastometry variables, perioperative fluid balance, renal function, mortality, intensive care unit, and hospital stay were also assessed.
RESULTS: The median cumulative blood loss was not different between the groups (HA: 835, HES: 700, and RL: 670 ml). However, 35% of RL patients required blood products, compared with 62% (HA) and 64% (HES group; P=0.0003). Significantly, more study solution had to be administered in the RL group compared with the colloid groups. Total perioperative fluid balance was least positive in the HA group [6.2 (2.5) litre] compared with the HES [7.4 (3.0) litre] and RL [8.3 (2.8) litre] groups (P<0.0001). Both colloids affected clot formation and clot strength and caused slight increases in serum creatinine.
CONCLUSIONS: Despite equal blood loss from chest drains, both colloids interfered with blood coagulation and produced greater haemodilution, which was associated with more transfusion of blood products compared with crystalloid use only.

Entities:  

Keywords:  Ringer's lactate; blood loss; coagulation; colloids; fluid regime; rotation thromboelastometry; transfusion

Mesh:

Substances:

Year:  2013        PMID: 24169821     DOI: 10.1093/bja/aet348

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  32 in total

1.  Perioperative Clinical Trials in AKI.

Authors:  David R McIlroy; Marcos G Lopez; Frederic T Billings
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

2.  Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial.

Authors:  Eero Pesonen; Hanna Vlasov; Raili Suojaranta; Seppo Hiippala; Alexey Schramko; Erika Wilkman; Tiina Eränen; Kaapo Arvonen; Maxim Mazanikov; Ulla-Stina Salminen; Mihkel Meinberg; Tommi Vähäsilta; Liisa Petäjä; Peter Raivio; Tatu Juvonen; Ville Pettilä
Journal:  JAMA       Date:  2022-07-19       Impact factor: 157.335

3.  Safety and efficacy of hydroxyethyl starch 6% 130/0.4/9 solution versus 5% human serum albumin in thoracic esophagectomy with 3-field lymph nodes dissection.

Authors:  Takeo Fujita; Naoya Okada; Yasumasa Horikiri; Takuji Sato; Hisashi Fujiwara; Shuhei Mayanagi; Jun Kanamori; Hiroyuki Yamamoto; Hiroyuki Daiko
Journal:  Surg Today       Date:  2019-01-02       Impact factor: 2.549

Review 4.  Fluid therapy and outcome: balance is best.

Authors:  Sara J Allen
Journal:  J Extra Corpor Technol       Date:  2014-03

5.  Effects of hydroxyethyl starch 6 % (130/0.4) on blood loss during cesarean delivery: a propensity-matched analysis.

Authors:  Abdullah S Terkawi; Sarah K Larkin; Siny Tsang; Jessica S Sheeran; Mohamed Tiouririne
Journal:  J Anesth       Date:  2016-06-30       Impact factor: 2.078

Review 6.  Fluid management in living donor hepatectomy: Recent issues and perspectives.

Authors:  Seong-Soo Choi; Sung-Hoon Kim; Young-Kug Kim
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

7.  STS/SCA/AmSECT/SABM Update to the Clinical Practice Guidelines on Patient Blood Management.

Authors:  Pierre Tibi; R Scott McClure; Jiapeng Huang; Robert A Baker; David Fitzgerald; C David Mazer; Marc Stone; Danny Chu; Alfred H Stammers; Tim Dickinson; Linda Shore-Lesserson; Victor Ferraris; Scott Firestone; Kalie Kissoon; Susan Moffatt-Bruce
Journal:  J Extra Corpor Technol       Date:  2021-06

Review 8.  Hydroxyethylstarch revisited for acute brain injury treatment.

Authors:  Martin A Schick; Malgorzata Burek; Carola Y Förster; Michiaki Nagai; Christian Wunder; Winfried Neuhaus
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

9.  Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients.

Authors:  Gabor Erdoes; Germaine Gerster; Giuseppe Colucci; Heiko Kaiser; Lorenzo Alberio; Balthasar Eberle
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.

Authors:  Mathias Opperer; Jashvant Poeran; Rehana Rasul; Madhu Mazumdar; Stavros G Memtsoudis
Journal:  BMJ       Date:  2015-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.